Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracervical bupivacaine block for pain after benign laparoscopic hysterectomy
ACTRN12621000973819Phase 4Recruiting
- Sponsor
- Tarana Lucky
- Start
- Nov 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine and epinephrine in postoperative pain (2 arms), sponsored by Tarana Lucky. Primary endpoint: Patient reported pain score at rest 60 minutes post-extubation using Numeric Rating Scale. Started Nov 2021; status: recruiting.
02
Drugs
bupivacaineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12621000973819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000973819.